Home / Gabapentin / Czechia
CZ ATC N02BF01 · updated 2 Nov 2026
Gabapentin shortage in Czechia
Is there a Gabapentin shortage in Czechia?
Yes. As of 2 Nov 2026, 10 Gabapentin products are reported short in Czechia, the first since 7 Apr 2026. The company estimate for the return is 18 Dec 2026 (latest 29 Feb 2028). Main reason: commercial decision or withdrawal.
Also short in Canada, Italy, Spain, Ireland, Austria, Belgium, Norway, Sweden. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | GABANOX 100MG 100MG CPS DUR 100 | Sandoz s.r.o., Praha | 7 Apr 2026 | 27 Aug 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GABANOX 300MG 300MG CPS DUR 100 | Sandoz s.r.o., Praha | 7 Apr 2026 | 2 Aug 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GABANOX 400MG 400MG CPS DUR 100 | Sandoz s.r.o., Praha | 20 Apr 2026 | 2 Aug 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GABAPENTIN TEVA B.V. 300MG 300MG CPS DUR 90 | Teva B.V., Haarlem | 5 Jun 2026 | 29 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GABAPENTIN TEVA B.V. 100MG 100MG CPS DUR 90 | Teva B.V., Haarlem | 16 Jun 2026 | 29 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GABAPENTIN TEVA B.V. 300MG 300MG CPS DUR 50 | Teva B.V., Haarlem | 9 Jul 2026 | 29 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GABANOX 100MG 100MG CPS DUR 90 | Sandoz s.r.o., Praha | 24 Jul 2026 | 16 Jun 2027 | Manufacturing problem Výrobní důvody |
| CZ | NEURONTIN 800MG 800MG TBL FLM 50 I | VIATRIS HEALTHCARE LIMITED, Dublin | 1 Oct 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | GABAPENTIN TEVA B.V. 400MG 400MG CPS DUR 50 | Teva B.V., Haarlem | 21 Oct 2026 | 29 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | GABANOX 300MG 300MG CPS DUR 50 | Sandoz s.r.o., Praha | 29 Oct 2026 | 18 Dec 2026 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.